Alison Cutts

Alison Cutts's picture
Alison Cutts
Senior Director
Xenon Pharmaceuticals

PhD in Genetics from Harvard University
Lead author on Nature Genetics paper describing positional cloning of the first zebrafish mutation corresponding to a human disease (sideroblastic anemia), validating zebrafish as a model system
5 Nature/Nature Genetics Publications
Extensive project management experience with both CROs and corporate partners, coordinating activities of cross functional teams up to 20 FTEs
Combined 20 years of genetics expertise both academic and industrial settings